Abstract
In this issue of Blood, Simmons et al report that low expression levels of the transcription factor Pax-5 in B-lineage progenitors results in the formation of highly proliferative B220+CD11b+ cells expressing both lymphoid and myeloid genes much in resemblance to cells generated in acute lymphoblastic leukemia (ALL)-like bi-phenotypic acute leukemia (BAL). 1 In contrast, high expression levels of Pax-5 in the progenitors result in expression of CD19 and apparently stable B-lineage commitment, suggesting a critical role for Pax-5 dose in both normal B-cell development and in the generation of leukemia. (Figure Presented).
Cite
CITATION STYLE
Sigvardsson, M. (2012, November 1). Transcription factor dose links development to disease. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-09-455113
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.